Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: Jul 15, 2023 (Letter of inquiry)

Later deadlines: Aug 15, 2023 (Full proposal), Jul 15, 2024 (Letter of inquiry), Aug 15, 2024 (Full proposal), Jul 15, 2025 (Letter of inquiry), Aug 15, 2025 (Full proposal)

Grant amount: Up to US $1,500,000

Funding uses: Research

Location of project: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Location of residency: United States, American Samoa, Guam, Northern Mariana Islands, Puerto Rico, Virgin Islands Show all

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization.

Avenir means future in French, and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators (ESI) proposing highly innovative studies that address NIH HIV/AID Research Priorities. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. The nexus with drug abuse should be clearly described. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support research approaches, both basic and clinical, which have the potential to benefit substance using populations with or at risk for HIV/AIDS by reducing HIV incidence, improving therapies for HIV, reducing the impact of comorbid conditions, and ultimately, eradicating HIV.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.